Literature DB >> 26872970

A Conserved Pocket in the Dengue Virus Polymerase Identified through Fragment-based Screening.

Christian G Noble1, Siew Pheng Lim2, Rishi Arora3, Fumiaki Yokokawa2, Shahul Nilar2, Cheah Chen Seh2, S Kirk Wright3, Timothy E Benson3, Paul W Smith2, Pei-Yong Shi4.   

Abstract

We performed a fragment screen on the dengue virus serotype 3 RNA-dependent RNA polymerase using x-ray crystallography. A screen of 1,400 fragments in pools of eight identified a single hit that bound in a novel pocket in the protein. This pocket is located in the polymerase palm subdomain and conserved across the four serotypes of dengue virus. The compound binds to the polymerase in solution as evidenced by surface plasmon resonance and isothermal titration calorimetry analyses. Related compounds where a phenyl is replaced by a thiophene show higher affinity binding, indicating the potential for rational design. Importantly, inhibition of enzyme activity correlated with the binding affinity, showing that the pocket is functionally important for polymerase activity. This fragment is an excellent starting point for optimization through rational structure-based design.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  RNA polymerase; crystallography; dengue virus (DENV); enzyme inhibitor; flavivirus; inhibitor; viral polymerase

Mesh:

Substances:

Year:  2016        PMID: 26872970      PMCID: PMC4861426          DOI: 10.1074/jbc.M115.710731

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation.

Authors:  D Beckett; E Kovaleva; P J Schatz
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution.

Authors:  Thai Leong Yap; Ting Xu; Yen-Liang Chen; Helene Malet; Marie-Pierre Egloff; Bruno Canard; Subhash G Vasudevan; Julien Lescar
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

3.  A fluorescence-based alkaline phosphatase-coupled polymerase assay for identification of inhibitors of dengue virus RNA-dependent RNA polymerase.

Authors:  Pornwaratt Niyomrattanakit; Siti Nurdiana Abas; Chin Chin Lim; David Beer; Pei-Yong Shi; Yen-Liang Chen
Journal:  J Biomol Screen       Date:  2011-01-10

Review 4.  The pathogenesis of dengue.

Authors:  Jamie Whitehorn; Cameron P Simmons
Journal:  Vaccine       Date:  2011-07-21       Impact factor: 3.641

5.  Inhibition of dengue virus polymerase by blocking of the RNA tunnel.

Authors:  Pornwaratt Niyomrattanakit; Yen-Liang Chen; Hongping Dong; Zheng Yin; Min Qing; J Frasier Glickman; Kai Lin; Dieter Mueller; Hans Voshol; Joanne Y H Lim; Shahul Nilar; Thomas H Keller; Pei-Yong Shi
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

6.  A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design.

Authors:  Brett R Beno; Kap-Sun Yeung; Michael D Bartberger; Lewis D Pennington; Nicholas A Meanwell
Journal:  J Med Chem       Date:  2015-03-03       Impact factor: 7.446

7.  Conformational flexibility of the Dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor.

Authors:  Christian G Noble; Siew Pheng Lim; Yen-Liang Chen; Chong Wai Liew; Lijian Yap; Julien Lescar; Pei-Yong Shi
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

8.  Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials.

Authors:  Cameron P Simmons; Marcel Wolbers; Minh Nguyet Nguyen; Jamie Whitehorn; Pei Yong Shi; Paul Young; Rosemary Petric; Van Vinh Chau Nguyen; Jeremy Farrar; Bridget Wills
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

9.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  1a/1b subtype profiling of nonnucleoside polymerase inhibitors of hepatitis C virus.

Authors:  Origène Nyanguile; Benoit Devogelaere; Leen Vijgen; Walter Van den Broeck; Frederik Pauwels; Maxwell D Cummings; Hendrik L De Bondt; Ann M Vos; Jan M Berke; Oliver Lenz; Geneviève Vandercruyssen; Katrien Vermeiren; Wendy Mostmans; Pascale Dehertogh; Frédéric Delouvroy; Sandrine Vendeville; Koen VanDyck; Koen Dockx; Erna Cleiren; Pierre Raboisson; Kenneth A Simmen; Gregory C Fanning
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

View more
  17 in total

1.  Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.

Authors:  Rishi Arora; Chong Wai Liew; Tingjin Sherryl Soh; Dorcas Adobea Otoo; Cheah Chen Seh; Kimberley Yue; Shahul Nilar; Gang Wang; Fumiaki Yokokawa; Christian G Noble; Yen Liang Chen; Pei-Yong Shi; Julien Lescar; Thomas M Smith; Timothy E Benson; Siew Pheng Lim
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

2.  The crystal structure of Zika virus NS5 reveals conserved drug targets.

Authors:  Wenqian Duan; Hao Song; Haiyuan Wang; Yan Chai; Chao Su; Jianxun Qi; Yi Shi; George F Gao
Journal:  EMBO J       Date:  2017-03-02       Impact factor: 11.598

3.  Identification of allosteric binding sites for PI3Kα oncogenic mutant specific inhibitor design.

Authors:  Michelle S Miller; Sweta Maheshwari; Fiona M McRobb; Kenneth W Kinzler; L Mario Amzel; Bert Vogelstein; Sandra B Gabelli
Journal:  Bioorg Med Chem       Date:  2017-01-16       Impact factor: 3.641

Review 4.  Mosquito-Borne Flaviviruses and Current Therapeutic Advances.

Authors:  Xijing Qian; Zhongtian Qi
Journal:  Viruses       Date:  2022-06-05       Impact factor: 5.818

5.  Suppression of Zika Virus Infection in the Brain by the Antiretroviral Drug Rilpivirine.

Authors:  Ilker Kudret Sariyer; Jennifer Gordon; Tricia H Burdo; Hassen S Wollebo; Eleonora Gianti; Martina Donadoni; Anna Bellizzi; Stephanie Cicalese; Regina Loomis; Jake A Robinson; Vincenzo Carnevale; Joseph Steiner; Mehmet H Ozdener; Andrew D Miller; Shohreh Amini; Michael L Klein; Kamel Khalili
Journal:  Mol Ther       Date:  2019-10-11       Impact factor: 11.454

Review 6.  Dengue Virus Non-Structural Protein 5.

Authors:  Abbas El Sahili; Julien Lescar
Journal:  Viruses       Date:  2017-04-24       Impact factor: 5.048

7.  [1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation.

Authors:  Yi-Hong Wan; Wen-Yu Wu; Song-Xin Guo; Shi-Jun He; Xiao-Dong Tang; Xiao-Yun Wu; Kutty Selva Nandakumar; Min Zou; Lin Li; Xiao-Guang Chen; Shu-Wen Liu; Xin-Gang Yao
Journal:  Acta Pharmacol Sin       Date:  2019-11-15       Impact factor: 6.150

8.  In Vitro Antiviral Activity of α-Mangostin against Dengue Virus Serotype-2 (DENV-2).

Authors:  Kingshuk Panda; Kalichamy Alagarasu; Poonam Patil; Megha Agrawal; Ashwini More; Naveen V Kumar; Prathama S Mainkar; Deepti Parashar; Sarah Cherian
Journal:  Molecules       Date:  2021-05-19       Impact factor: 4.411

9.  Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling.

Authors:  Siew Pheng Lim; Christian Guy Noble; Cheah Chen Seh; Tingjin Sherryl Soh; Abbas El Sahili; Grace Kar Yarn Chan; Julien Lescar; Rishi Arora; Timothy Benson; Shahul Nilar; Ujjini Manjunatha; Kah Fei Wan; Hongping Dong; Xuping Xie; Pei-Yong Shi; Fumiaki Yokokawa
Journal:  PLoS Pathog       Date:  2016-08-08       Impact factor: 6.823

10.  Development and validation of RdRp Screen, a crystallization screen for viral RNA-dependent RNA polymerases.

Authors:  Federica Riccio; Sandeep K Talapatra; Sally Oxenford; Richard Angell; Michela Mazzon; Frank Kozielski
Journal:  Biol Open       Date:  2019-01-02       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.